Birger Jansson
Geen lopende functies
Profiel
Birger Jansson worked as Director of Research at Affibody AB, Vice President-Research & Development at CEPHEID, and Corporate VP-Research & Development at DiaSorin SpA from 2009 to 2011.
He holds a doctorate degree from the Royal Institute of Technology.
Eerdere bekende functies van Birger Jansson
| Bedrijven | Functie | Einde |
|---|---|---|
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Hoofd Techniek/Wetenschap/O&O | - |
| DIASORIN S.P.A. | Hoofd Techniek/Wetenschap/O&O | - |
| CEPHEID | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Birger Jansson
| Royal Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DIASORIN S.P.A. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
